Clinical Trial: A Study of DII235 in Adults With Elevated Lipoprotein(a)

U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07235046) titled 'A Study of DII235 in Adults With Elevated Lipoprotein(a)' on Nov. 14.

Brief Summary: The main purpose of this study is to determine the safety and efficacy of DII235 in adults with elevated lipoprotein(a).

Study Start Date: Dec. 29

Study Type: INTERVENTIONAL

Condition: Lipoprotein Disorder

Intervention: DRUG: DII235

Solution for injection

DRUG: Saline

solution for injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Novartis Pharmaceuticals

Disclaimer: Curated by HT Syndication....